Virpax Pharmaceuticals Inc (VRPX) Stock: What Does the Chart Say Monday?

The market has been high on Virpax Pharmaceuticals Inc (VRPX) stock recently. VRPX gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Virpax Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on VRPX!

See Full VRPX Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With VRPX Stock Today?

Virpax Pharmaceuticals Inc (VRPX) stock has gained 12.39% while the S&P 500 is lower by -0.13% as of 2:27 PM on Monday, Mar 11. VRPX is up $0.56 from the previous closing price of $4.52 on volume of 509,705 shares. Over the past year the S&P 500 is higher by 32.71% while VRPX is lower by -39.88%. VRPX lost -$11.62 per share in the over the last 12 months.

More About Virpax Pharmaceuticals Inc

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray. Click Here to get the full Stock Report for Virpax Pharmaceuticals Inc stock.